3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
11
Prostatic Neoplasms
9
Uterine Neoplasms
2
Hyperthermia
2
Endometrial Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Rhabdomyosarcoma
1
Recurrence
1
Ovarian Neoplasms
1
Neoplasms
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Head and Neck Neoplasms
1
Genital Neoplasms, Female
1
Esophageal Squamous Cell Carcinoma
1
Esophageal Neoplasms
1
Endometrial Clear Cell Adenocarcinoma
1
Directly Observed Therapy
1
Cervical Adenocarcinoma
1
Carcinoma, Renal Cell
1
Adenocarcinoma
1
Interventions
pembrolizumab
2
lenvatinib
2
aldesleukin
2
Paclitaxel
2
Cisplatin
2
Carboplatin
2
Adoptive Transfer
2
trastuzumab deruxtecan
1
tivozanib
1
liposomal doxorubicin
1
fludarabine
1
dostarlimab
1
belzutifan
1
atezolizumab
1
Vaccines, Synthetic
1
Therapeutic Touch
1
Taxes
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Standard of Care
1
Specimen Handling
1
Radiation
1
Practice Guidelines as Topic
1
Platinum
1
Papillomavirus Vaccines
1
Nivolumab
1
Nelfinavir
1
Imiquimod
1
Hysterectomy
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Vulvar Neoplasms
×
Brachytherapy
×
Clear all
NCT05242861
2022-02-16
RetroBT
Zhejiang Cancer Hospital
Recruiting
300 enrolled